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Abstract. We have studied the subcellular distribution
of the a, and a2 subunits of the skeletal muscle dihy-
dropyridine (DHP) receptor with immunofluorescence
labeling of normal and dysgenic (mdg) muscle in cul-
ture. In normal myotubes both a subunits were local-
ized in clusters associated with the Ttubule membranes
of longitudinally as well as transversely oriented Ttu-
bules. The DHP receptor-rich domains may represent
the sites where triad junctions with the sarcoplasmic
reticulum are being formed. In cultures from dysgenic
muscle the a, subunit was undetectable and the distri-
bution patterns of the a2 subunit were abnormal. The
a2 subunit did not form clusters nor was it discretely
localized in the Ttubule system. Instead, a2 was found
diffusely distributed in parts of the Tsystem, in struc-
HE dihydropyridine (DHP)' receptor of skeletal mus-
cle plays a major role in the transduction of mem- Tbrane depolarization into muscle contraction, called
excitation-contraction (E-C) coupling. Located in the mem-
brane ofthe T-tubules, the DHP receptor is believed to func-
tion as voltage sensor in E-C coupling as well as slow,
L-type Call channel (see reference 3 for review).
The purified DHP receptor isolated from Ttubule mem-
branes is composed of at least four polypeptides. The a,
subunit has a molecular mass of 170-200 kD, carries the
DHP-binding site (5, 12, 41, 42) and reacts with a mAb that
inhibits slow Call currents (28) . The cDNA encoding this
protein has been cloned and shown to contain the character-
istics of a voltage-gated ion channel (43). The presence of
a sequence similar to the putative voltage-sensing element
of the Na channel (29) supports the idea that the a, subunit
of the DHP receptor is the voltage sensor involved in E-C
coupling. The expression of the cDNA encoding the a,
polypeptide in L-cells was accompanied by the appearance
of Cal+ currents, indicating that this subunit alone is suffi-
cient for channel activity (33).
1. Abbreviationsusedin thispaper: DHP, dihydropyridine; E-C, excitation-
contraction; HS, horseserum; nulg, musculardysgenesis; SR, sarcoplasmic
reticulum.
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tures in the perinuclear region and in the plasma mem-
brane. These results suggest that an interaction be-
tween the two a subunits is required for the normal
distribution of the a2 subunit in the T-tubule mem-
branes. Spontaneous fusion of normal non-muscle cells
with dysgenic myotubes resulted in a regional expres-
sion of the a, polypeptide near the foreign nuclei, thus
defining the nuclear domain of a Ttubule membrane
protein in multi-nucleated muscle cells. Furthermore,
the normal intracellular distribution of the a2 polypep-
tide was restored in domains containing a foreign "res-
cue" nucleus; this supports the idea that direct interac-
tions between the DHP receptor a, and a2 subunits
are involved in the organization of the junctional
Ttubule membranes.
Three other polypeptides copurify with the a, subunit of
the DHP receptor: a2 , ß, and -y . However, the functions of
these polypeptides as well as their possible interactions with
the a, polypeptide are unknown. The a2 subunit is a glyco-
protein of 140 kD molecular mass under reducing conditions
and 170-200 kD without reduction (24, 26, 42, 45, 46). The
differences in molecular mass values upon reduction of the
disulfide bonds may be accounted for by the dissociation of
a small polypeptide, referred to as the S subunit. The pri-
mary structure of the a2 polypeptide contains three putative
membrane spanning domains and a large extracellular do-
main but it does not show any sequence similarities to other
known proteins (10). Although the a2 polypeptide is not re-
quired for DHP sensitive Cat+ conductance (33), coexpres-
sion of the a2 subunit with the cardiac a, subunit in Xeno-
pus oocytes causes a doubling of the Cal+ current (25). We
have previously demonstrated the colocalization of the 012
subunit and the a, subunit in the membranes of the func-
tional Ttubules of skeletal muscle in vivo (13) . During de-
velopment, however, the two a polypeptides are expressed
differentially in that a2 is abundant in muscle of newborn
rats while levels of a, subunit expression are initially low
but rise dramatically two weeks postnatally (27). These
results suggest that the function of the a2 subunit may not
be limited to its association with the muscle DHP receptor.Muscular dysgenesis (mdg) in mice is a lethal recessive
mutation characterized by the inability of skeletal muscle to
contract (6, 30). Myotubes grown in culture from muscle of
homozygous mdglmdg mice lack E-C coupling (21, 36), the
slow DHP-sensitive Cal+ current (2), as well as the charge
movement associated with voltage sensing in this process (1).
Microinjection of an expression plasmid carrying the gene
of the a, subunit of the skeletal muscle DHP receptor can
restore E-C coupling and the slow Cal+ current (1, 44).
These results suggest that the primary defect ofthe mdg mu-
tant is in the gene of the a, subunit. The mutation is be-
lieved to reside in the structural gene, resulting in a failure
to express the a, polypeptide. The lack of the a, subunit
does not seem to alter the expression of the DHP receptor
012 subunit (22), however, the cytological distribution of the
a2 subunit in dysgenic muscle has not been described.
Co-cultures of dysgenic myotubes with spinal cord cells
and fibroblasts from normal mice have also been shown to
restore E-C coupling coupling (8, 23) and slow Call con-
ductance (2, 40). This "rescue" of normal functions in dys-
genic muscle cells has been explained by spontaneous fusion
of normal non-muscle cells with dysgenic myotubes (7).
Normal non-muscle nuclei that are incorporated into the
defective myotubes are believed to be capable of express-
ing the a, polypeptide and thus reconstituting E-C cou-
pling functions. However, direct evidence for the de novo ex-
pression of the a, polypeptide in rescued myotubes is still
missing.
In the present study we have used mAbs against the a,
and the a2 subunit of the skeletal muscle DHP receptor to
study the expression and distribution patterns of the DHP
receptor a subunits in cultured myotubes from normal and
dysgenic mice. We report the colocalization of both a sub-
units in clusters associated with the membranes of the de-
veloping T-tubules in normal myotubes. Furthermore, we
show that the absence of a, in dysgenic myotubes causes an
aberrant distribution of the a2 subunit and that the lack of
a, as well as the abnormal distribution of a2 can be reversed
by rescue with normal non-muscle cells. These results pro-
vide strong evidence that an interaction between the a, and
the a2 subunit of the DHP receptor is required for their
normal organization in the junctional T-tubule membranes.
Materials andMethods
Animals
Newborn and embryonic mice, both homozygous mutant dysgenic,
mdglmdg, and their normal littermates, +Imdg? (+/+ or +Imdg) were ob-
tained by dated pregnancies of heterozygous matings. No morphological,
histological, orphysiological differencesbetween control +/+ ofthe strain
or +Imdg? mice have been reported. Sprague-Dawley rats (Charles River
Breeding Laboratories, Wilmington, MA) were mated overnight and dated
pregnancies were assessed by remains ofvaginal plugs. 15-d embryonic rats
were used to obtain spinal cord cells.
CellCultures
Primary muscle cultures were prepared from 18-d embryonic or newborn
mdglmdg or +Imdg? mice. Myoblasts were harvested using a modification
ofpreviously published methods (8, 21). Hindlimb muscle was digested at
37°C for 15 min with intermittent aspiration in asolution of0.125% trypsin
and 0.05% pancreatin in Cat+ and Mg2+ free HBSS. Digestion was stopped
by adding an equal volume of complete medium, consisting of DME with
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10% horse serum (HS; Gibco Laboratories, Grand Island, NY), 10% FBS
(Gibco Laboratories), and 2% chick embryo extract. The cell suspension
was filtered through gauze and centrifuged. The pellet was resuspended in
plating medium which contains three parts complete medium to one part
conditioned medium reserved from 5-d muscle cultures. Dysgenic cultures
were preplated for 1 h on plastic Petri dishes to enrich for myoblasts which
were plated onto carbon-coated coverslips with 0.1% gelatin at 5 x 10,
cells per 13-mm coverslip (two coverslips per 35-mm dish). Normal cul-
tures, which tended to have fewer myoblasts and form fewer myotubes if
plated by the same method, were preplated at 3.5 x 105 cells per 1%
gelatin-coated 60-mm Primaria dishes. After 48 h, as an additional myo-
blast enrichment step, the normal cultures were treated with Dispase and
replated onto coverslips prepared as above (9). Dysgenic cultures treated
with Dispase were similar to untreated cultures, so the conventional plating
method was followed. Once myotubes had formed and cultures were near
confluency, the cultures were treated with 101AM 1 ßo-arabinofuranosylcy-
tosine hydrochloride, Ara-C, (Sigma Chemical Co., St. Louis, MO) to pre-
vent fibroblastic overgrowth. Cultures were maintained in contraction me-
dium (DME, 10% HS, 1.25% chick embryo extract) in a humidified 37°C
incubator. Quiescentcultures (both dysgenic and normal) were fedmedium
containing 12 mM K+. Our experience over many years (37) in micro-
scopic and electrophysiological studies of normal and dysgenic muscle
proves that spontaneous action potentials (in dysgenic) and contraction in
normal myotubes are completely absent at this K+ concentration. Cultures
were fixed two to three weeks following plating.
For "rescued" co-cultures, dysgenic myoblasts were plated as above. Rat
cells (spinal cord or fibroblasts) were added at the onset of fusion, 3-5 d
after initial plating. The degree ofrescue, indicated by the onsetofsponta-
neous contractions, was similar in co-cultures of dysgenic muscle with ei-
ther spinal cord cells or fibroblasts(8). Co-cultures weretreated withAra-C
and maintained in contraction medium as above.
Rat spinal cord cells were prepared from spinal cords of 15-d embryos
byamethod similar to that used for harvestingembryonic mouse spinalcord
cells (8) except that most of the spinal ganglia were retained. Cells were
mechanically dissociated in contraction medium and added to fusing dys-
genic myoblasts at 1 x 106 cells per 35-mm dish.
Rat fibroblasts were obtained from two cell lines. FR cells (American
Type Culture Collection, Rockville, MD) were maintained in DME with
10% HS. Alternatively, fibroblastcells (JRF) were derived fromaspontane-
ous transformation within a culture prepared from newborn rat sciatic nerve
sheath. These cells were maintained in DME, 10% HS, 5% FBS. Both
fibroblast lines were equally fusible with dysgenic myotubes and were
equivalent in their ability to effect rescue. Cells were routinely passed once
a week and were added to fusing dysgenic myoblasts at 2 x 104 cells per
35-mm dish. Rescued cultures were fixed 11 to 18 d following addition of
rat cells.
ImmunofuorescenceLabeling
ofCulturedMuscle Cells
The co-cultures used in the "rescue" experiments were incubated in 10
kg/mlHoechstnucleardye #33342 (Polysciences, Inc., Warrington, PA) for
45 min at room temperature and rinsed several times in PBS, pH 7.3, before
fixation. All cultures were fixed at -20°C in methanol for 10 min and then
rinsed in several changes ofPBS. Subsequently, the cultures were incubated
with 10% normal goat serum in PBS. 0.1% BSA (PBSBSA) for 30 min or
longer and then incubated inprimary antibodies forat least 2 h at room tem-
perature or overnightat 4°C. After washing in five changes ofPBS/BSA the
cultures were incubated in fluorochrome-conjugated secondary antibodies
for 1-2 h at roomtemperature and washed again. Finally, they were mounted
in 90% glycerol, 0.1 M Tris, pH 8.0, with 5 mg/ml p-phenylene diamine
to retard photobleaching.
QuantitativeAnalysisofRescuedCultures
To quantitate the expression ofthe a, subunit in rescued co-cultures, cov-
erslips were screened for myotubes which were free of fibroblastic over-
growth. The analyzable myotubes were scored as positive or negative with
respect to expression of the a, subunit. Then coverslips were rescreened
for myotubes which contained at least one foreign nucleus. Quantitation of
normally distributed a2 subunit in rescued myotubes required more strin-
gency. Myotubes were screened segment by segment (one segment extend-
ing -150 /Am) and scored for normal or abnormal a2 distribution patterns.
A few segments with ambiguous staining patterns were not counted. Subse-
quently, myotubes were rescreened for the presence of foreign nuclei.
1346Table I. Specificity ofAntibodies Used in This Study
Theantibodies havebeen previously used in immunofluorescenceand immunogold (*) studies on tissue sections and cultures from rat as well as from mouse skele-
tal muscle. AP, affinity purified antibody.
Antibodies
The following primary antibodies were used: mouse mAb 1A (specific for
the a, subunit of the DHP receptor) (26) and mAb 20A (specific for the
a2 subunit) (27) both use(: ata concentration of0.1 pM IgG. Rabbit affinity
purified antibody aTT (against T-tubule proteins), aPM (against plasma
membrane proteins) both described in reference 14, and an affinity puri-
fied antibody against a-actinin (4). As secondary antibodies, rhodamine-
conjugated goat anti-mouse IgG (BCA/Cappel Products, Organon Tech-
nika, Malvern, PA) and fluorescein-conjugated goat anti-rabbit IgG (Miles
Laboratories, Inc., Elkhart, IL) were used at dilutions of 1:500 and 1:400,
respectively. For specificity of antibodies, see Table I.
Results
We have studied the distribution and association of the DHP
receptor a, and a2 subunits in muscle cultures of normal
and dysgenic mice using mAbs against both DHP receptor
a subunits as well as an affinity purified antibody against
Ttubule membranes.
Normal Myotubes
Normal mouse muscle cellswere cultured for approximately
three weeks under conditions permitting a high degree of
spontaneous contractile activity. Cultures immunolabeled
with antibodies against several myofibrillar components
(a-actinin, myosin, actin, and titin) showed that the myo-
tubes inany culture dish reach varying degrees ofsarcomeric
organization (Flucher et a1., unpublished results). Some
myotubes showed no cross striation ofany ofthe myofibrillar
components. Many myotubes achieved cross-striated orga-
nization of myofibrillar components that assemble early in
development but showed no cross striations under phase
contrast optics. A smaller number of cellswere cross-striat-
ed with respect to all examined myofibrillar proteins as well
as under phase contrast optics. The transverse organization
of the Ttubule system, which occurs late in sarcomere for-
mation (14) was achieved only in a small proportion of the
myotubes.
Immunofluorescence labeling of myotubes with the anti-
bodies against the al and a2 subunits of the DHP receptor
resulted in punctate labeling patterns, suggesting that both
subunits are concentrated in small clusters rather than
diffusely distributed in the membranes (Fig. 1) . These DHP
receptor clusters were located throughout the cytoplasm.
Double labeling of either a subunit antibody with the Ttu-
bule antibody (aTT) showed that the DHP receptor clusters
in the cytoplasm coincide with the tubules of the developing
Ttubule system. In poorly differentiated myotubes contain-
ing randomly oriented Ttubules the DHP receptor-rich do-
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mains were lined up along the tubules at irregular intervals
(Fig. 1, a and c) . In myotubes that had achieved a higher de-
gree of differentiation in their contractile apparatus, Ttu-
bules were longitudinally oriented in between the myofibrils
and the DHP receptor-rich domains were first seen periodi-
cally aligned along the Ttubules (Fig. 1 d). Only after this
alignment of DHP receptor-rich domains (presumably rep-
resenting developing triads) had occurred did the Ttubules
themselves rearrange into a transverse orientation. In well-
developed regions of myotubes the transverse component of
the Tsystem became prevalent and the longitudinal tubules
disappeared (Fig. 1 b'; see also Fig. 5, c and d).
Dysgenic Myotubes
Muscle cultures from homozygous dysgenic mice (mdg/
mdg) and their normal siblings (+lmdg.~ were compared
with respect to the expression and distribution patterns ofthe
DHP receptor a subunits. Dysgenic myotubes were noncon-
tractile and the rate at which they developed following fusion
was slower than that ofnormal myotubes. A smaller number
of myotubes achieved as high a degree of organization in
their contractile elements than that found in normal cultures
(Flucher et al., manuscript in preparation) .
Immunolabeling with the antibody against the a, subunit
of the DHP receptor under conditions that labeled normal
myotubes, resulted in no immunolabeling of dysgenic myo-
tubes (Fig. 2 a). The absence of a, label was complete in
all cells of dysgenic cultures, supporting the idea that the
mdg/mdg mutation results in the complete absence of a,
subunit expression in skeletal muscle cells. Double labeling
for al and Ttubules (with the aTT antibody) demonstrated
the presence of an extensive Ttubule network in a, nega-
tive cultures (Fig. 2 b), suggesting that the development of
the Ttubules is not dependent upon expression of the a,
polypeptide. Immunolabeling of the a2 subunit of the DHP
receptor yielded a strong fluorescent signal in dysgenic myo-
tubes. However, the labeling patterns were different from the
a2 distribution in normal myotubes (compare Fig. 1 c and d
to Fig. 2 c). Myotubes that had an apparently normal Tsys-
tem (Fig. 2 d) did not show the normal punctate distribution
of DHP receptor-rich domains but showed patches of a2 la-
bel colocalizing only with parts of the Ttubules, whereas
much of the Tsystem contained no a2 (Fig. 2, c and d) . In
many myotubes in which these patches coincided with the
Tsystem, the a2 patches appeared wider than the typical
Ttubules suggesting that they represent distortions of the
Tsystem or ofits precursor. In addition to cytoplasmic struc-
tures labeled with a2, diffuse or patchy a2 labeling of the
Tissue sections Cell culture
(in vivo) (in vitro)
Antigen Code Type Rat Mouse Rat Mouse C2 Cell Reference
DHP, a, lA mouse mAb +* + + + + 13, 26
DHP, 012 20A mouse mAb +* + + + nd 13,27
T-tubule aTT rabbit AP +* + + + + 14
Sarcolemma apm rabbit AP + nd + + nd 14
a-Actinin - rabbit AP + + + + + 4, 13Figure 1 . Normal mousemyotubes were double immunofluorescence labeled with antibodies against the a subunits of the skeletal muscle
DHP receptor (a, b, c, and d) and against Ttubules (a', b', c', and d') . The corresponding phase contrast images are shown in a", b",
c", andd" . Both the a, (a and b) andthe az (c andd) subunits ofthe DHPreceptor appeared in punctate staining patterns, which colocal-
ized withT -tubules atdifferent stages ofdevelopment: randomly oriented tubules (a'and c') as well as longitudinal orientedtubules (between
arrows in d'') showed no periodicity oftheDHPreceptor clusters, whereas in more highly differentiated myotubes with beginning transverse
orientation of the Ttubules (examples indicated with arrows in d) the DHP receptor clusters were aligned in rows across the myotube
(b ; arrows) . N, nuclei . Bars, 10 jm.
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1348Figure2. Dysgenic (mdg/mdg) muscle cultures doublelabeled with antibodies against the a subunits oftheDHP receptor and with a T-tubule
antibody. Dysgenic myotubes showed no a t label (a ; myotube outlined with dashed line) but often labeled intensely for the a2 Subunit
(c) . The structure of the Ttubule system appeared normal (b and d) but the distribution patterns of the a2 subunit were abnormal (c) in
dysgenic myotubules : label for the 012 subunit was patchy (arrows) and colocalized only with parts of the Tsystem (c and d) . In addition,
a2 label could be observed in the plasma membrane (c ; arrowheads) . Bars, 10 Am .
plasma membrane was commonly observed in dysgenic
myotubes (Fig . 2 c) .
The aberrant distribution patterns of a 2 immunolabel
varied widely in dysgenic cultures . Two more examples of
typical a2 labeling patterns in dysgenic myotubes with the
corresponding fluorescence images of the Ttubule system
are shown in Fig . 3 to demonstrate that the normal differenti-
ation ofthe Ttubule system is not hindered by the lack of or-
ganization in the DHP receptor complex . In many cells the
Ttubule system appeared normal whereas the a 2 label was
restricted to compartments which were frequently located in
the perinuclear region and contained a2 as well as Ttubule
antigens (Fig . 3 a) . These compartments appeared dilated,
and more like cisternae than tubular structures. Henceforth
these structures will be called a2/TTcontaining compart-
ments. Normal looking Ttubules that did not label with the
antibody against a2 could often be observed in close prox-
imity to the abnormal a2/TTcontaining structures (Fig . 3
a) . In some regions of dysgenic myotubes a2 label was
completely absent from cytoplasmic structures . However,
even in such extreme cases of a2 deficiency the Tsystem
developed normally, as seen by the transverse arrangement
oftheT-tubules (Fig . 3 b) . Phase contrast images ofdysgenic
myotubes show that their general appearance was normal
(Fig. 3b" ; Fig . 4 b') . Double labeling ofnormal and dysgenic
myotubes with antibodies against the a2 subunit and against
the myofibrillar component a-actinin (Fig . 4,a and b) shows
that the myofibrillar development was similar in myotubes of
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the normal and the mutant phenotype of a2 distribution .
Thus, distorted a2 distribution patterns do not result from a
lack of differentiation or from degeneration of dysgenic myo-
tubes .
We attempted the further characterization of the a2/TT
containing compartments in dysgenic cells . The perinuclear
location ofthese structures was reminiscent of ER or Golgi
apparatus staining and suggested the possibility that the a2
subunits were partially retained in compartments ofthe bio-
synthetic pathway. However, double labeling of myotubes
with antibodies against a2 and markers for the ER or fluo-
rescent WGA showed no colocalization of a2 with the ER
or Golgi apparatus, respectively (not shown) . Our observa-
tion that 012 in dysgenic myotubes occurs diffusely distribut-
ed or in patches in the plasma membrane, suggests the possi-
bility of faulty targeting of this polypeptide to the plasma
membrane. Indeed, double labeling of a2 with an affinity-
purified antibody against plasma membranes that did not
cross-react with T-tubules in normal myotubes (14), revealed
the existence of specific plasma membrane components in
the a2/TTcontaining compartments (Fig . 5, a and b) .
Since mdg/mdgmyotubes are noncontractile and contrac-
tile activity seems to promote differentiation of cultured
mouse muscle cells (37), we compared the aberrant a2 dis-
tribution patterns in dysgenic myotubes with the distribution
patterns of "quiet normal (+/mdg .7) cultures (Fig . 5, c and
d) . The lack of contractile activity achieved by elevating the
KCl concentration in the culture medium to 12mM (37) had
1349Figure 3 Two examples of abnormal a2 labeling patterns in dysgenic myotubes with poorly (a) and highly developedT-tubules (b) . Myo-
tubes were double labeled for the DHP receptor a2 subunit (a and b) and Ttubules (a' and d) ; the corresponding phase contrast images
are shown (a" and b') . Immunolabel for the a2 Subunit did not occur in punctate patterns as observed in normal cultures. Instead, a2 was
frequently colocalized withTtubule specific antigens in structures preferentially located in the perinuclear region (a ; arrows) while normal,
randomly oriented Ttubules (upper portion of the myotube) were devoid ofa2 label . Little or no a2 was expressed in the myotube shown
in b, however, the Ttubules achieved the highest degree of organization reached in culture, as indicated by their transverse orientation
at the I-A interfaces (arrowheads) . Bars, 10 Am .
no apparent effect on the distribution of the DHP receptor
a2 subunits. Normal quiescent cultures did not exhibit as
many cross-striated myotubes as active cultures . However, in
many of the normal myotubes rendered quiescent for 14 d
myofibrillar cross striations were apparent (not shown) and
the 012 subunits occurred in normal clusters colocalized
with theT-tubules oflongitudinal as well as cross-striated or-
ganization (Fig . 5, c and d) . The a 2/TTcontaining com-
partments seen in dysgenic myotubes were not found in silent
normal cultures, suggesting that the lack of contraction is not
responsible for the loss of normal a 2 distribution in dys-
genic cells .
RescuedMyotubes
Dysgenic muscle cells are capable of spontaneously fusing
with normal muscle as well as with non-muscle cells (7) and
such fusion has been shown to restore slow Call currents as
well as E-C coupling to dysgenic myotubes (8) . Fusion of
mdglmdg myotubes with rat non-muscle cells created hetero-
karya of mouse myotubes with a small proportion of rat
nuclei, which could be reliably distinguished from the host
cell nuclei by the lack of heterochromatin that characterizes
the mouse nuclei (see Figs . 6 and 7) .
Immunolabeling of dysgenic myotubes co-cultured with
normal non-muscle cells with the antibody against the DHP
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receptor a, subunit resulted in regionally confined labeling
of some myotubes (Fig . 6, a and c) . Double labeling with the
fluorescent nuclear dye (Hoechst #33342) showed that these
a,-positive regions always coincided with at least one rat
nucleus (Fig . 6) . However, not all rat nuclei incorporated
into dysgenic myotubes displayed a, expression . Quantita-
tion of a, expression with respect to the number of rat
nuclei incorporated into dysgenic cultures showed that
32.7% (f3.2) of all myotubes (n = 149) possessed foreign
nuclei and 10.9% (t1.3) of all myotubes expressed the a,
polypeptide in regions where at least one foreign nucleus was
located . Thus, a third of the rat non-muscle nuclei incorpo-
rated into mdglmdg myotubes were expressing the a,
subunit ofthe skeletal muscleDHP receptor and could there-
fore be considered "rescue" nuclei .
The distribution patterns of a, in rescued myotubes were
punctate (Fig . 6, a and c) and the DHP receptor clusters
colocalized with the Ttubules (not shown) . This organiza-
tion resembled that of the DHP receptor-rich domains of
normal myotubes . Furthermore, in rescued myotubes the a,
antibody did not label any cytoplasmic structures similar to
the a2/TTcontaining compartments found in dysgenic myo-
tubes. The segment of the myotube in which a, was ex-
pressed could be as short as 40 pm or up to 500-pm long
with an average of270 pm in length . Typically it would con-
1350Figure 4. Normal and dysgenic myotubes double labeled for the DHP receptor 012 subunit (a and b) and the myofibrillar protein a-actinin
(a' and ö), with the corresponding phase contrast images (a" and b") . Punctate (a) and dysgenic a2 labeling patterns (b) can be observed
in normal and mdg/mdg myotubes, respectively, which show the same degree of myofibrillar differentiation . Whereas in normal myotubes
a2 clusters begin to align transversely in regions of a-actinin cross-striations (arrowheads), no relationship between the a2 patches (ar-
rows) and a-actinin cross striations can be observed in dysgenic myotubes . Bars, 10 gym .
tain three to four mouse nuclei in addition to the rat rescue
nucleus (Fig. 6 b) . The position of the rescue nucleus within
this a,-positive domain was highly variable and in some
cases the rat nucleus was located at the very edge of the la-
beled region .
Triple labeling with antibodies against a2, dTT and the
fluorescent nuclear dye showed that regions of normally
clustered a2 distribution (Fig . 7, a and d) always occurred
at or adjacent to a rat nucleus (Fig . 7) . Quantitation ofthese
results revealed 36.4% (±2.4) of analyzable myotube seg-
ments (n = 118) contained a rat nucleus, but only 16.9
(±0.9) of the segments displayed a normal labeling pattern
for the a2 subunit . Thus 46% of the segments containing a
rat nucleus were rescued with respect to the a2 subunit .
The Ttubules appeared normal in these rescued regions and
no a2/TTcontaining compartments were observed (Fig . 7,
a, c, d, andf ) . However, the plasma membrane in these do-
mains commonly displayed diffuse a2 staining (Fig. 7 d)
suggesting that normal organization of a2 was not com-
pletely restored in the region of the rescue nuclei .
Discussion
Normal Distribution oftheaSubunits
oftheDHPReceptor
In primary cultures of normal skeletal muscle the a, and the
a2 subunit of the DHP receptor were localized in clusters.
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This distribution pattern is similar to that observed in the
myogenic cell line C2 using the same antibody (M . E . Mor-
ton, Holy Cross College, Worcester,MA ; personal commu-
nication) . The clusters of DHP receptors colocalized with
the tubules ofthe developing T-tubule system, a finding that
is consistent with the localization ofthe DHP receptor in the
Ttubule membranes of mature muscle (13, 16, 20, 24) . The
non-uniform distribution ofDHP receptors in the developing
Ttubules suggests that the Ttubule membranes consist of at
least two membrane domains : DHP receptor-rich domains,
which may be the sites where triad junctions with the SR
form, and unspecialized membrane regions in between the
DHP receptor clusters. Electron microscopic studies show
that junctions between T-tubules and SR (diads, triads, and
other constellations) are formed in myotubes of comparable
developmental stages in vivo (17, 34) and in vitro (8, 40) .
Presently we do not have evidence as to whether DHP
receptor-rich domains exist in the absence of a close contact
with the SRmembranes. It is conceivable thatDHP receptor
clustering precedes the first interactions with theSR and that
these specialized domains of the Ttubule membranes subse-
quently form junctions with the SR . However, reports that
triads can be found in rare cases in the absence of the DHP
receptor a, subunit in dysgenic muscle cells (8, 34) and
more frequently in dysgenic myotubes treated with calcito-
nin gene-related peptide (18) suggest that DHP receptor a,
subunit clustering is not a prerequisite for triad formation.
Our finding that both a subunits appeared as clusters with
135 1Figure 5 . Further characterization of a2 distribution (control experiments) . Dysgenic myotubes double labeled with a2 and an antibody
against plasma membraneproteins (a and b, respectively) showed both antigens colocalized in a structure inthe perinuclear region (arrows) .
This colocalization was found in myotubes with and without diffuse U2 label in the plasma membrane . Normal myotubes were grown un-
der conditions prohibiting muscle contraction and were double labeled with a2 (c) and T-tubule antibodies (d) . The distribution patterns
of both antigens were normal and showed a high degree of differentiation in the E-C coupling system, suggesting that inactivity did not
impale the normal distribution of the a 2 subunit or the differentiation of the Tsystem. Bars, 10 tm .
identical distribution patterns in cultured muscle suggests
that the a, and a2 subunits are colocalized in the DHP
receptor-rich domains developing in muscle in vitro . Using
the same antibodies as in the present study, Western blot
analysis revealed that the expression of the a, and a2
subunits during development is differentially regulated (27) .
Skeletal muscle of newborn rats expresses the a 2 subunit in
substantial amounts and its concentration increases steadily
over a period of three weeks . In contrast, expression of the
a, subunit is very low at birth but increases dramatically
two weeks later. In the present immunocytochemical study
on cultured muscle, however, we have found no evidence for
a pool of the a2 subunit apart from the a, subunit. On the
contrary, the localization of both subunits seemed to be
closely associated in normal myotubes of all developmental
stages observed .
Localization oftheDHPReceptora Subunits
in Dysgenic Muscle
Immunolabeling of dysgenic myotubes with the antibody
against the a, subunit gave no detectable signal in any of
the myotubes . The mdg mutation is believed to reside in the
structural gene, resulting in the lack or severe underexpres-
sion of the a, polypeptide (22, 44) . Our results support this
idea by demonstrating the complete absence of the a,
subunit on the cellular level . If there were still a low level
of a, expression and the remaining subunits behave nor-
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mally, one could expect them to formDHP receptor clusters,
which would be detectable with immunofluorescence, in re-
duced quantities . However, the total lack of a, label shown
in our experiments provides further evidence that the a,
subunit is not expressed in muscles of dysgenic mice .
The a2 subunit of the DHP receptor was expressed in
dysgenic myotubes, confirming existing evidence from im-
munoblot analysis of dysgenic muscle (22) . However, the
distribution patterns of a2 were grossly altered in mdg/mdg
cultures . Normal DHP clusters were not found . Parts of
the T-tubule system were devoid ofa2 and wherever a2 and
the Ttubule antigens were colocalized in the cytoplasm, the
a2/TT-containing structures were distinct from normal Ttu-
bule profiles . In electron microscopic studies of dysgenic
muscle in vivo and in vitro swollen membrane compart-
ments have been noted (35 ; Powell, unpublished results),
and it is possible that some of the membrane compartments
described as swollen SR may actually correspond to the
a2/TT-containing structures seen with immunofluorescence .
The frequent observations of diffuse a 2 label in the plasma
membrane of dysgenic myotubes and the finding that the
plasma membrane specific components are colocalized with
the perinuclear a2/TTcontaining structures suggests that
the lack of the a, subunit may cause problems with the tar-
geting of specific components to the plasma membrane and
Ttubules . The completely aberrant distribution of a2 in
dysgenic myotubes was not due to a general state ofdegener-
1352Figure 6 . Restoration of DHP receptor a, expression in dysgenic myotubes by fusion with normal cells . Co-cultures of mdg/mdg myo-
tubes and normal non-muscle cells from rat were double labeled with the a, subunit antibody (a and c) and the nuclear dye (Hoechst
#33342) (b andd) . The chromatin ofrat nuclei (RN) appearshomogeneous ; in contrast, the mousehostcell nuclei (MN) exhibitheterochro-
matin . Immunolabel for the a, subunit could be seen in regions of dysgenic myotubes containing at least one rat nucleus . Expression of
a, was restricted to a nuclear domain that usually contained several mouse nuclei in addition to the rat nucleus (a and b; between double
arrowheads) . The regions outside the "rescued" domain and "non-rescued myotubes (arrowheads) show no a, expression. In the rescued
regions a, appeared in its normal punctate distribution pattern (c) . Bar, 10 gym .
ation, since myofibrillar organization was intact and, more
significantly, T-tubules in dysgenic myotubes were for the
most part normally developed and were able to achieve a de-
gree of differentiation similar to that in normal myotubes
(Flucher et al ., manuscript in preparation) . Thus, the altered
a 2 distribution patterns in mdglmdg myotubes suggest that
the a2 subunit requires the presence of the a, subunit for its
aggregation into DHP receptor-rich domains as well as for
its specific localization in theT-tubule system . Alternatively,
the aberrant a2 distribution might be explained by indirect
effects of the mutation on muscle morphology. One pos-
sibility is that the lack of contractile activity during develop-
ment in vitro could prevent the proper organization of the
DHP receptors in the Ttubules . However, normal myotubes
grown under conditions that inhibited spontaneous contrac-
tion did not show any signs ofadverse effects ofthis treatment
on the clustering or the normal organization of the DHP
receptor subunits . Furthermore, inactivity in vivo does not
reduce the number of triads (32) . Other secondary causes
such as altered regulation of intracellular Cal+ levels, can-
not be completely ruled out . However, we believe that the
aberrant distribution of the a2 subunit is most directly ex-
plained by the disruption of the interactions between the a,
and a2 subunits that normally may lead to the aggregation
of the DHP receptor complexes into clusters in the Ttubule
system .
Flucher et al . DHP Receptor a Subunits in Cultured Myotubes
Rescue ofthe Expressionand Distribution
oftheDHP Receptora Subunits
If the described aberrations in the expression and distribu-
tion patterns of the DHP receptor a2 subunit are caused by
the lack of the a, subunit of the DHP receptor, reconstitu-
tion of dysgenic myotubes with the a, polypeptide should
restore normal structures and functions . Expression and
normal distribution of the a, subunit was restored in dys-
genic myotubes fused with normal cells . This finding is in
agreement with results from electrophysiological studies on
rescued mdglmdg muscle showing that the slow Cat+ cur-
rent and voltage gating are restored (1, 2) . Our immunocyto-
chemical localization of the a, subunit in myotubes with
foreign nuclei showed that a third of the normal (rat) nuclei
in rescued myotubes expressed the a, subunit . Pavlath and
her colleagues (31) reported that not all heterokaryons of
mouse myoblast and human non-myogenic cells expressed
the foreign protein, e.g ., 49% expressed human sarcomeric
myosin heavy chain and 87% expressed human sarcolemmal
neuronal cell adhesion molecule . In the present study, those
foreign nuclei that apparently did not express the a, poly-
peptide may reflect a population of the non-muscle cells
which was capable of fusing with the muscle cells, but was
insensitive to the regulatory signals inducing the expression
of muscle specific gene products . Alternatively, the coexis-
1353Figure 7 . Restoration of normal distribution patterns of the DHPreceptor a2 subunit in regions of dysgenic myotubes containing normal
foreign nuclei . Co-cultures of mdg/mdg myotubes and normal non-muscle cells were triple labeled with antibodies against the a2 subunit
(a and d) andT-tubules (c andf) as well as with the nucleardye (b and e) . The distribution patterns of both antigens in the cytoplasm
were normal in rescued domains of poorly differentiated (a-c) as well as highly differentiated myotubes (df ) . Immunolabel of a2 was
punctate and coincided with the Ttubules . Whereas aberrant a2/TTcontaining structures (as shown in Figs . 2 and 3) were absent from
these regions, diffuse a2 label in the plasma membrane, unaccompanied by Ttubule staining could be observed (a and d ; arrowheads) .
RN, rat nucleus ; MN, mouse nucleus . Bars, 10 Am .
tence of foreign nuclei with different a, expression patterns
may be indicative of nuclear specializations within themul-
tinucleated muscle cells, as hasbeen reported for acetylcho-
line receptor transcripts (15) .
Immunolabel for a, was always found associated with a
foreign rat nucleus, covering an area (i.e ., "nuclear domain")
of the myotube that often included severalhostmousenuclei .
Nucleardomains appear to vary in size depending on thena-
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ture of the protein and the target organelle of the molecule
(for review see reference 19) . For instance, the distribution
ofcertain proteins targeted for nuclei (39),the Golgiappara-
tus, or the contractile apparatus (31) is limited to the source
nucleus anda fewneighboring nuclei, whereas solublecyto-
plasmic proteins become widely distributed in the myotube
(19, 39) . Both situations, limited as well as wide distribution,
have been described forplasma membrane proteins (31, 38) .
1354This is the first report of the nuclear domain ofa membrane
protein localized in the T-tubule system and shows that a nor-
mal nucleus incorporated into a diseased muscle cell may be
capable ofproviding its gene products to a region that corre-
sponds to approximately four host nuclei and is finite in
length. The distribution of the DHP receptor in its nuclear
domain may occur by local insertion of transport vesicles,
by lateral diffusion of the polypeptide in the T-tubules that
exist during most of development or through the migration
of the rescue nucleus itself (11), leaving behind a trail of a,
mRNA or the polypeptide. Several examples in which the
rescue nucleus was found at one end of the nuclear domain
rather than in the center support this latter possibility.
In addition to the rescue of at subunit expression per se,
the normal distribution patterns of both a subunits were re-
stored by the fusion ofdysgenic myotubes with normal cells.
This could clearly be seen when the a, subunit appeared in
its normal clustered distribution in rescued cells. Further-
more, in rescued cultures labeled for a2, regions of appar-
ently normal a2 distribution were observed in the midst of
distorted labeling patterns. Wherever such "normal regions
were found they coincided with the location of a foreign nu-
cleus. However, more than half of the foreign nuclei in res-
cued myotubes were not localized in regions of "normal a2
distribution. Since two thirds ofthe foreign nuclei were also
not expressing at, we believe that the same population of
nuclei is responsible for both phenomena. Thus, newly syn-
thesized a, subunits in rescued myotubes did not only as-
sume a normal clustered distribution themselves, but appar-
ently caused the aggregation of the a2 subunits in DHP
receptor-rich domains of the Ttubules as well.
The subunit composition of the DHP receptor complex
has been proposed on the basis of the co-purification of the
a,, a2, ß, and y polypeptides from isolated triads (24).
However, up to now, there has been relatively little evidence
for in situ interactions between the subunits or for possible
functions of the subunits other than a, . In the present study
we have demonstrated that: (a) the a subunits of the skeletal
muscle DHP receptor coexist in DHP receptor-rich domains
of the developing Ttubule system; (b) the a2 subunit fails
to form clusters in the absence of the a, subunit; and (c)
that reconstitution of a, subunit expression restores the
normal organization of the a2 subunit in the Ttubule mem-
branes. Taken together these results provide strong evidence
for a direct interaction between the two a subunits of the
skeletal muscle DHP receptor and suggest apossible role for
these interactions in the specialization of the junctional
membrane of the Ttubules.
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